INFORMED CONSENT FOR INVESTIGATIONAL CHEMOTHERAPY - PATIENTS AND PHYSICIANS PERCEPTIONS
INFORMED CONSENT FOR INVESTIGATIONAL CHEMOTHERAPY - PATIENTS AND PHYSICIANS PERCEPTIONS
复制标题
DOI：
10.1200/jco.1984.2.7.849
复制
发表时间：
1984-01-01
影响因子：
45.3
通讯作者：
CHERRY, R
中科院分区：
文献类型：
--
作者：
PENMAN, DT;HOLLAND, JC;CHERRY, R
研究了3个癌症中心的144名患者和68名医生对同意程序的看法，他们在1-3周前参加了65项研究方案中的1项化疗。患者积极回忆手术过程，并在很大程度上依赖医生的建议。他们认为大多数医生希望他们接受; 29%的人认为他们参与决定不受鼓励。接受的主要原因是信任医生，相信治疗会有所帮助，担心疾病（被视为高度严重）会变得更糟。近1/4的人不记得治疗是研究性的。同意书在69%的人的决策中没有发挥作用。医生认为，对大多数患者来说，治疗益处将超过潜在的问题;他们认为41%的患者不太渴望了解治疗细节，1/3的患者避免讨论，1/3的患者在决策时被动。双方的知觉定势无意中限制了患者的自主决策。
Patients (144) and 68 physicians at 3 cancer centers were studied for their perceptions of the consent procedure, in which they participated 1-3 wk earlier, for chemotherapy by 1 of 65 investigational protocols. Patients recalled the procedure positively and relied heavily on physician''s advice. They felt most physicians wanted them to accept; 29% felt their participation in the decision was not encouraged. Primary reasons for accepting were trust in the physician, belief the treatment would help and fear the disease (viewed as highly serious) would get worse without it. Nearly 1/4 did not recall the information given that treatment was investigational. The consent form played no role in decision-making for 69%. Physicians believed therapeutic benefits would exceed potential problems for most patients; they viewed 41% of the patients as less than eager for details of treatment, 1/3 as avoiding the discussion and 1/3 passive in decision-making. The perceptual set of both parties places inadvertent constraint on patients'' autonomy in decision making.